BELLICUM PHARMACEUTICALS INC - COM (BLCM)

Historical Holders from Q1 2014 to Q3 2020

Symbol
BLCM
Type / Class
Equity / COM
All holders as of 30 Sep 2020
Q3 2020
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2020 Q3 0 $0 -$166,000 0
2020 Q2 22,374 $166,000 $7.42 1
2020 Q1 22,374 $105,000 -$23,115,620 $4.69 1
2019 Q4 17,486,780 $22,557,204 -$2,351,721 $1.29 46
2019 Q3 19,741,326 $20,725,809 -$5,648,793 $1.05 61
2019 Q2 24,141,356 $42,026,786 -$4,185,117 $1.70 72
2019 Q1 25,252,463 $85,093,171 +$6,376,368 $3.37 87
2018 Q4 23,519,400 $68,667,507 -$4,346,817 $2.92 89
2018 Q3 24,353,752 $150,012,790 -$8,513,316 $6.16 98
2018 Q2 25,669,059 $189,440,846 +$55,764,821 $7.38 94
2018 Q1 18,239,051 $119,650,574 -$420,614 $6.56 87
2017 Q4 18,320,102 $154,069,337 -$5,403,918 $8.41 89
2017 Q3 18,383,012 $212,366,897 -$903,981 $11.55 87
2017 Q2 18,514,506 $216,255,359 -$34,732,608 $11.68 83
2017 Q1 21,330,780 $263,216,123 +$41,105,981 $12.34 97
2016 Q4 19,544,618 $266,200,808 +$10,646,750 $13.62 78
2016 Q3 18,641,131 $370,954,367 +$21,784,116 $19.90 69
2016 Q2 17,640,683 $228,620,171 +$25,329,638 $12.96 66
2016 Q1 15,950,595 $149,089,208 -$19,126,895 $9.35 77
2015 Q4 16,411,002 $332,653,845 +$21,575,010 $20.27 80
2015 Q3 15,851,374 $230,319,696 -$10,049,412 $14.53 80
2015 Q2 15,708,880 $334,123,652 +$20,098,383 $21.27 81
2015 Q1 14,721,086 $339,520,199 +$11,482,867 $23.17 71
2014 Q4 13,167,470 $298,733,200 +$289,321,200 $23.04 54
2014 Q1 300 $7,395 $24.65 1